Other
Lawrence Livermore National Laboratory
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
60.0%-27% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
Failure Rate
33.3%
2 terminated/withdrawn out of 6 trials
Success Rate
60.0%
-26.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed trials have results
Key Signals
3 with results
Enrollment Performance
Analytics
Early Phase 1
4(66.7%)
Phase 1
1(16.7%)
N/A
1(16.7%)
6Total
Early Phase 1(4)
Phase 1(1)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT05014841Not ApplicableEnrolling By Invitation
The Neural Coding of Speech Across Human Languages
Role: collaborator
NCT03802721Early Phase 1Completed
Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet
Role: collaborator
NCT03631667Early Phase 1Completed
Ultralow Dose PAH Binary Mixture Study
Role: collaborator
NCT03318978Early Phase 1Completed
Benzo[a]Pyrene Ultralow Dose-Response Study
Role: collaborator
NCT01092689Phase 1Withdrawn
The Role of Meat-borne Carcinogens in Pancreatic Cancer
Role: collaborator
NCT01261299Early Phase 1Terminated
Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer
Role: collaborator
All 6 trials loaded